This site is intended for managed care professionals in the U.S.
Professionals in Canada should visit CanadaCGM.com
 |
Lower A1c and Reduce Hospital/ED Use in Members with Insulin-Treated Type 2 Diabetes via Real-Time Continuous Glucose Monitoring |
|
|
|
Emerging Landscape of Continuous Glucose MonitoringDiabetes Technology & Therapeutics |
|
|
|
Association of Real-time Continuous Glucose Monitoring With Glycemic Control and Acute Metabolic Events Among Patients With Insulin-Treated DiabetesThe Journal of the American Medical Association |
|
|
|
Comparing real-time and intermittently scanned continuous glucose monitoring in adults with type 1 diabetes (ALERTT1): a 6-month, prospective, multicenter, randomized controlled trialThe Lancet |
|
|
|
Effect of Continuous Glucose Monitoring on Glycemic Control in Patients with Type 2 Diabetes Treated with Basal Insulin: A Randomized Clinical TrialThe Journal of the American Medical Association |
(Formerly) Vice President, Ambulatory Clinical Pharmacy Programs_PCM
Henry Ford Health System/Health Alliance Plan of Michigan
Read More
Manager, Clinical Pharmacy Services
BlueCross BlueShield North Carolina
Read More
(Formerly) Vice President, Clinical Strategy and Programs and Industry Relations
MagellanRx Management
Read More
Assistant Professor of Pediatrics
Director of Strategic Collaboration
Diabetes Clinic CPT Co-Director
Section of Pediatric Diabetes & Endocrinology
Baylor College of Medicine/Texas Children's Hospital
Read More
This web site is supported by an educational grant from DexCom, Inc.
